Gallia Levy

Chief Tech/Sci/R&D Officer at SPARK THERAPEUTICS, INC.

Health Technology

Profile

Gallia G.
Levy is currently the Chief Medical & Strategy Officer at Spark Therapeutics, Inc. Prior to this, she worked as an Associate Group Medical Director at Genentech, Inc. and as an Associate Group Medical Director-Hematology at Roche Holding AG.

Gallia Levy active positions

Companies	Position	Start
SPARK THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	-

All active positions of Gallia Levy

Former positions of Gallia Levy

Companies	Position	End
ROCHE HOLDING AG	Corporate Officer/Principal	-
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Chief Tech/Sci/R&D Officer	-

See the detail of Gallia Levy's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gallia Levy's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ROCHE HOLDING AG	Health Technology

Private companies	2
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology
Spark Therapeutics, Inc. Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.	Health Technology